Results 41 to 50 of about 157,420 (243)

In vitro permissivity of bovine cells for wild-type and vaccinal myxoma virus strains [PDF]

, 2007
Myxoma virus (MYXV), a leporide-specific poxvirus, represents an attractive candidate for the generation of safe, non-replicative vaccine vector for non-host species.
Jean-Luc Duteyrat, Pignolet Béatrice, Stéphane Bertagnoli, Foucras Gilles, Béatrice Pignolet, Bertagnoli, Stéphane, Duteyrat, Jl, Aude Allemandou, Jacqueline Gelfi, Allemandou Aude, Bertagnoli Stéphane, Gelfi, Jacqueline, Foucras, Gilles, Duteyrat Jean-Luc, Gilles Foucras, Allemandou, Aude, Duteyrat, Jean-Luc, Pignolet, Béatrice, Gelfi Jacqueline   +18 more
core   +1 more source

A new inhibitor of apoptosis from vaccinia virus and eukaryotes. [PDF]

, 2007
A new apoptosis inhibitor is described from vaccinia virus, camelpox virus, and eukaryotic cells. The inhibitor is a hydrophobic, multiple transmembrane protein that is resident in the Golgi and is named GAAP (Golgi anti-apoptotic protein).
Hollinshead, M, Smith, GL, van Kuppeveld, FJM, van Kuppeveld Frank J. M, Lu, X., Smith, G.L., Xin Lu, Gubser, C, Smith Geoffrey L, Bergamaschi, D., Bergamaschi Daniele, Hollinshead Michael, Caroline Gubser, Hollinshead, M., van Kuppeveld, FJ, Bergamaschi, D, Kuppeveld, F.J.M. van, Gubser Caroline, Geoffrey L Smith, Gubser, C., Frank J M van Kuppeveld, Michael Hollinshead, Lu Xin, Daniele Bergamaschi, Lu, Xin, Lu, X   +25 more
core   +2 more sources

Pathogen reduction in human plasma using an ultrashort pulsed laser. [PDF]

PLoS ONE, 2014
Pathogen reduction is a viable approach to ensure the continued safety of the blood supply against emerging pathogens. However, the currently licensed pathogen reduction techniques are ineffective against non-enveloped viruses such as hepatitis A virus ...
Shaw-Wei D Tsen, David H Kingsley, Karen Kibler, Bert Jacobs, Sara Sizemore, Sara M Vaiana, Jeanne Anderson, Kong-Thon Tsen, Samuel Achilefu   +8 more
doaj   +1 more source

Suitability of vaccinia virus and bovine viral diarrhea virus (BVDV) for determining activities of three commonly-used alcohol-based hand rubs against enveloped viruses [PDF]

, 2007
Background A procedure for including activity against enveloped viruses in the post-contamination treatment of hands has been recommended, but so far no European standard is available to implement it.
Jochen Steinmann, Rabenau, Holger, Steinmann Jochen, Kampf, Günter, Holger Rabenau, Kampf Günter, Günter Kampf, Steinmann, Jochen, Rabenau Holger   +8 more
core   +1 more source

Human annexin A6 interacts with influenza A virus protein M2 and negatively modulates infection [PDF]

, 2012
The influenza A virus M2 ion channel protein has the longest cytoplasmic tail (CT) among the three viral envelope proteins and is well conserved between different viral strains.
Béatrice Nal, François Kien, Ma, H, Kien, F, Leo Lit Man Poon, Zhang, Y, Tse, KS, Poon, LLM, Maniere, M, Nadège Lagarde, Yang Zhang, Maxime Manière, Nal, B, Kong San Tse, Huailiang Ma, Lagarde, N   +15 more
core   +1 more source

Inactivation of Enveloped Bovine Viral Diarrhea Virus and Non-Enveloped Porcine Parvovirus Using Low-Pressure Non-Thermal Plasma

Life, 2021
As the worldwide population has been experiencing since 2020, viruses represent a serious threat to global well-being. To avoid viral transmission through surgery or medical examination, sterilization of medical material is needed.
Florian Le Bras, Gaëlle Carré, Yasmina Aguemon, Marius Colin, Marie-Paule Gellé   +4 more
doaj   +1 more source

Identification of novel neutralizing determinants for protection against HCV

Hepatology, EarlyView., 2022
Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua, Anne F. Pihl, Anna Offersgaard, Rodrigo Velázquez‐Moctezuma, Carlos R. Duarte Hernandez, Elias H. Augestad, Ulrik Fahnøe, Christian K. Mathiesen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jens Bukh, Judith M. Gottwein   +12 more
wiley   +1 more source

Characterization of a quasi-enveloped, fast replicating hepevirus from fish and its use as hepatitis E virus surrogate [PDF]

, 2019
Hepatitis E virus (HEV) is an emerging concern for the safety of plasma-derived medicinal products. The lack of an efficient cell culture system hampers the studies on HEV biology as well as validation studies to test the capacity of virus reduction ...
Roth, Nathan J., Ros, Carlos, Bochud, Maëlle, Schäfer, Wolfram   +3 more
core   +1 more source

Human milk inhibits some enveloped virus infections, including SARS-CoV-2, in an intestinal model

Life Science Alliance, 2022
Human milk blocks some enveloped, but not non-enveloped, virus infections in a primary human fetal intestinal model and the transcriptomic data points towards inhibition of entry mediated by ATP1A1.
Ikrame Aknouch, Adithya Sridhar, Eline Freeze, Francesca Paola Giugliano, Britt J van Keulen, Michelle Romijn, Carlemi Calitz, Inés García-Rodríguez, Lance Mulder, Manon E Wildenberg, Vanesa Muncan, Marit J van Gils, Johannes B van Goudoever, Koert J Stittelaar, Katja C Wolthers, Dasja Pajkrt   +15 more
doaj   +1 more source

Structural conservation of HBV-like capsid proteins over hundreds of millions of years despite the shift from non-enveloped to enveloped life-style

Nature Communications, 2023
Nackednaviruses and hepatitis B virus (HBV) have a common non-enveloped viral ancestor. While HBV acquired an envelope during evolution, nackednaviruses remained non-enveloped. Here, Pfister et al.
Sara Pfister, Julius Rabl, Thomas Wiegand, Simone Mattei, Alexander A. Malär, Lauriane Lecoq, Stefan Seitz, Ralf Bartenschlager, Anja Böckmann, Michael Nassal, Daniel Boehringer, Beat H. Meier   +11 more
doaj   +1 more source